Skip to content
★ Sign in to follow
SB

Scott B. Capps

Executive
Total declarations
79
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€1.1M

Latest filing published 15 Mar 2021 for Artivion, INC., €24k.

Filing timeline

BuySale
Scott B. Capps

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

Scott B. Capps: trading record in brief

All filings by Scott B. Capps on record concern Artivion, Inc. Between 25 February 2008 and 12 March 2021, the trades on record add up to 79 filings.

Sales make up the whole of the open-market record (8 sales, €1.1M). Outside the open market, there are 62 share grants and 9 option exercises.

The record was last updated on 15 March 2021 with a share grant (€24k) in Artivion, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Scott B. Capps

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations77 total
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    29,058 USD11SEC
    1,160 shares@ US$25.051.2% of flowCommon StockSEC:0000784199-21-000089:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    5,837 USD11SEC
    233 shares@ US$25.050.2% of flowCommon StockSEC:0000784199-21-000089:1
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    5,010 USD11SEC
    205 shares@ US$24.440.2% of flowCommon StockSEC:0000784199-21-000066:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    14,306 USD11SEC
    563 shares@ US$25.410.6% of flowCommon StockSEC:0000784199-21-000041:1
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    0SEC
    3,176 shares0Common StockSEC:0000784199-21-000041:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    0SEC
    3,548 shares0Common StockSEC:0000784199-21-000017:0
  • ◇
    VP, Clinical ResearchExecutivesArtivion, Inc.
    99,700 USD14SEC
    10,000 shares@ US$9.9728.8% of flowCommon StockSEC:0000784199-20-000224:0
  • ▼
    VP, Clinical ResearchExecutivesArtivion, Inc.
    178,553 USD34SEC
    8,366 shares@ US$21.342751.6% of flowCommon StockSEC:0000784199-20-000224:1
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    4,716 USD11SEC
    233 shares@ US$20.240.8% of flowCommon StockSEC:0000784199-20-000074:1
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    0SEC
    1,998 shares0Common StockSEC:0000784199-20-000074:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    8,726 USD11SEC
    350 shares@ US$24.931.6% of flowCommon StockSEC:0000784199-20-000055:1
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    0SEC
    2,320 shares0Common StockSEC:0000784199-20-000055:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    39,562 USD12SEC
    1,510 shares@ US$26.207.3% of flowCommon StockSEC:0000784199-20-000039:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    7,650 USD11SEC
    292 shares@ US$26.201.4% of flowCommon StockSEC:0000784199-20-000039:2
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    0SEC
    1,998 shares0Common StockSEC:0000784199-20-000039:1
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    0SEC
    3,176 shares0Common StockSEC:0000784199-20-000021:0
  • ◇
    VP, Clinical ResearchExecutivesArtivion, Inc.
    61,200 USD12SEC
    10,000 shares@ US$6.126.3% of flowCommon StockSEC:0000784199-19-000166:0
  • ▼
    VP, Clinical ResearchExecutivesArtivion, Inc.
    179,097 USD25SEC
    7,184 shares@ US$24.9318.5% of flowCommon StockSEC:0000784199-19-000166:1
  • ▼
    VP, Clinical ResearchExecutivesArtivion, Inc.
    57,100 USD30SEC
    2,000 shares@ US$28.555.8% of flowCommon StockSEC:0000784199-19-000131:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    0SEC
    3,092 shares0Common StockSEC:0000784199-19-000076:1
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    59 USD11SEC
    2 shares@ US$29.700.0% of flowCommon StockSEC:0000784199-19-000076:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    13,477 USD11SEC
    466 shares@ US$28.921.4% of flowCommon StockSEC:0000784199-19-000076:2
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    0SEC
    2,813 shares0Common StockSEC:0000784199-19-000066:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    32,284 USD11SEC
    1,087 shares@ US$29.702.4% of flowCommon StockSEC:0000784199-19-000030:0
  • ◆
    VP, Clinical ResearchExecutivesArtivion, Inc.
    68,005 USD12SEC
    2,358 shares@ US$28.845.0% of flowCommon StockSEC:0000784199-19-000018:0

25 of 77 declarations